I am deeply passionate about creating new innovations by bridging the gap between AI and various domains, including but not limited to biotechnology and novel drug development. I earned my Ph.D. in Computer Science from Emory University, receiving the prestigious Graduate Student Research Award. My research there spanned Natural Language Processing (NLP), healthcare, and the development of new pharmaceuticals. During my Ph.D., I co-founded Deargen, an AI-based drug development company. I played a key role in securing Series A and B funding, and as we finalized the Series B round, we reached a pivotal milestone as Amyloid Solution acquired us. Another major accomplishment was our precise prediction of COVID-19 drug efficacies, showcasing our technological prowess. Throughout my career, I have authored several top-tier papers and filed over ten patents. Currently, I am seeking opportunities to further advance my career and contribute to groundbreaking innovations in various fields.
Powered by Jekyll and Minimal Light theme.